ENDRA Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update

Go back to ENDRA Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update

ENDRA Life Sciences (NDRA) Tops Q3 EPS by 1c; Reports Cash and Cash Equivalents of $11.8M

November 15, 2021 4:50 PM EST

ENDRA Life Sciences (NASDAQ: NDRA) reported Q3 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07).

For earnings history and earnings-related data on ENDRA Life Sciences (NDRA) click here.

... More